Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases.

dc.contributor.authorVadwai, Viral
dc.contributor.authorBoehme, Catharina
dc.contributor.authorNabeta, Pamela
dc.contributor.authorShetty, Anjali
dc.contributor.authorRodrigues, Camilla
dc.date.accessioned2012-07-11T09:36:58Z
dc.date.available2012-07-11T09:36:58Z
dc.date.issued2012-04
dc.identifier.citationVadwai Viral, Boehme Catharina, Nabeta Pamela, Shetty Anjali, Rodrigues Camilla. Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases. Indian Journal of Medical Research. 2012 Apr; 135(4): 560-561.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/139431
dc.language.isoenen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385244/en_US
dc.subject.meshDisease Susceptibility
dc.subject.meshHumans
dc.subject.meshIsoniazid --pharmacokinetics
dc.subject.meshMycobacterium tuberculosis --drug effects
dc.subject.meshRifamycins --pharmacokinetics
dc.subject.meshTuberculosis, Pulmonary --drug therapy
dc.titleNeed to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijmr2012v135n4p560.pdf
Size:
220.04 KB
Format:
Adobe Portable Document Format
Description:
Journal article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: